[Association of Serum Myeloperoxidase and Lipid Levels With Coronary Artery Lesion Severity and Major Adverse Cardiovascular Events in Patients With Acute Coronary Syndrome]. [PDF]
Li Y, Li X.
europepmc +1 more source
[Exploration of the mechanisms of portal hypertension driven by metabolic disorders in non-cirrhotic stages of metabolic-associated fatty liver disease]. [PDF]
Zhao YQ, Wang Y, Liu JJ, You H, Zhao JJ.
europepmc +1 more source
[Proportion and clinical characteristics of probable metabolic-associated fatty liver disease-related cirrhosis in cryptogenic cirrhosis]. [PDF]
Wang Y +7 more
europepmc +1 more source
[Noninvasive scores for predicting liver-related events in patients with metabolic dysfunction-associated fatty liver disease]. [PDF]
Gao YK +6 more
europepmc +1 more source
[Across-sectional study on the association between steatotic liver disease and its subtypes, cardiovascular health status, and extrahepatic comorbidity]. [PDF]
Guan JB +8 more
europepmc +1 more source
[Efficacy and safety of laparoscopic nephron-sparing surgery for giant renal angio-myolipoma]. [PDF]
Duan P +6 more
europepmc +1 more source
[Buffering effect of intensive lipid lowering on mortality risk in type 2 diabetic patients with chronic kidney disease and challenging glycemic management: a cohort study based on dual metabolic trajectories]. [PDF]
Wang X, Yang J, Liang S, Dong Z.
europepmc +1 more source
[Construction norms for the tiered diagnosis and treatment and standardized management center of metabolic-associated fatty liver disease]. [PDF]
Fatty Liver and Alcoholic Liver Disease Study Group +2 more
europepmc +1 more source
[Research progress on the pathological mechanisms and clinical translation of ferroptosis in necrotizing enterocolitis]. [PDF]
Luo J, Li WB.
europepmc +1 more source
[Fibroblast growth factor 21 improves alcoholic liver disease by regulating gut microbiota in mice]. [PDF]
Wu GC +5 more
europepmc +1 more source

